1-(2,3-dihydro-6-hydroxychromen-4-ylideneamino)-3-(4-(4-methylpiperazin-1-yl)butyl)imidazolidine-2,4-dione

ID: ALA473292

Chembl Id: CHEMBL473292

Max Phase: Preclinical

Molecular Formula: C21H29N5O4

Molecular Weight: 415.49

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CN1CCN(CCCCN2C(=O)CN(/N=C3\CCOc4ccc(O)cc43)C2=O)CC1

Standard InChI:  InChI=1S/C21H29N5O4/c1-23-9-11-24(12-10-23)7-2-3-8-25-20(28)15-26(21(25)29)22-18-6-13-30-19-5-4-16(27)14-17(18)19/h4-5,14,27H,2-3,6-13,15H2,1H3/b22-18+

Standard InChI Key:  MPQQCGOFEJUTCO-RELWKKBWSA-N

Alternative Forms

1. Parent:

   

   ALA473292

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 415.49

Molecular Weight (Monoisotopic): 415.2220

AlogP: 1.17

#Rotatable Bonds: 6

Polar Surface Area: 88.92

Molecular Species: NEUTRAL

HBA: 7

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 9.64

CX Basic pKa: 8.28

CX LogP: 0.51

CX LogD: -0.27

Aromatic Rings: 1

Heavy Atoms: 30

QED Weighted: 0.55

Np Likeness Score: -0.61

References

1. Du L, Li M, Yang Q, Tang Y, You Q, Xia L..  (2009)  Molecular hybridization, synthesis, and biological evaluation of novel chroman I(Kr) and I(Ks) dual blockers.,  19  (5): [PMID:19185489] [10.1016/j.bmcl.2009.01.022]

Source

Source(1):

• Scientific Literature